Background: The pylorus plays a key role in the control of gastric content outflow. Impairment of pyloric physiology has been observed in gastroparesis, particularly when associated with diabetes mellitus or opioid intake or after antireflux surgery. New tools have been developed to identify pyloric dysfunction in routine care, including functional luminal impedance planimetry (FLIP). As such, a new therapeutic strategy targeting the pylorus, namely endoscopic pyloromyotomy (G-POEM), has received increasing attention and emerged as a promising treatment for gastroparesis.
Purpose: The present review details the involvement of the pyloric pathophysiology in gastroparesis, as well as clinical results of G-POEM according to the current literature.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077918 | PMC |
| http://dx.doi.org/10.1111/nmo.14529 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of gastric per-oral endoscopic myotomy remains similar after failure of interventional techniques in refractory gastroparesis.
Clin Res Hepatol Gastroenterol
November 2024
Assistance Publique- Hôpitaux de Paris, Service d'Hépato-Gastro-Entérologie, Hôpital Louis Mourier, DMU ESPRIT AP-HP Nord, Colombes F-92700, France; Université Paris Cité, INSERM, Centre de recherche sur l'Inflammation, F-75018 Paris, France. Electronic address:
Background And Aims: Gastric per-oral endoscopic myotomy (G-POEM) is a new therapeutic option for the treatment of refractory gastroparesis. However, the outcome of G-POEM after the failure of gastric electrical stimulation (GES) or other pylorus-targeting therapies has been poorly reported.
Methods: Data were collected from patients referred for G-POEM for refractory gastroparesis.
Endoscopic pyloromyotomy for treatment of gastroparesis: A new standard or still an experimental approach?
Best Pract Res Clin Gastroenterol
August 2024
Department of Hepatogastroenterology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic; Institute of Physiology, Charles University in Prague, Prague, Czech Republic; Faculty of Medicine, Ostrava University, Ostrava, Czech Republic. Electronic address:
Gastroparesis (GP) can be a severe and debilitating disease. Its pathophysiology is complex and not completely understood. Two principal mechanisms are responsible for the development of symptoms - gastric hypomotility and pylorospasm.
View Article and Find Full Text PDFConvergent Comodulation Reduces Interindividual Variability of Circuit Output.
eNeuro
September 2024
NJIT, Newark, New Jersey 07102
Ionic current levels of identified neurons vary substantially across individual animals. Yet, under similar conditions, neural circuit output can be remarkably similar, as evidenced in many motor systems. All neural circuits are influenced by multiple neuromodulators, which provide flexibility to their output.
View Article and Find Full Text PDFEvaluation of soluble co-inhibitors and co-stimulators levels of the immune response in gastric cancer.
J Surg Oncol
September 2024
Translational Research Laboratory, Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.
Article Synopsis
- The study investigates the levels of various soluble immune mediators in gastric cancer (GC) patients compared to healthy controls, focusing on potential therapeutic targets for treatment.
- Results indicate low levels of sPD-1, sPD-L2, and sGal9, while levels of sPD-L1, sTIM-3, sGITR, and sGITRL were higher in GC patients, with variations based on cancer stages and specific tumor locations.
- Findings suggest a potential link between certain soluble mediators (sPD-1, sTIM-3, sGal9) and disease progression, as well as the association of low sGITR with increased mortality within the first
Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in Gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
West Afr J Med
March 2024
Department of Pathology, College of Medicine University of Ibadan, Ibadan, Oyo State, Nigeria.
Background And Objective: The demonstration of HER2 in gastric adenocarcinoma (GA) tissues by immunohistochemistry assists in deciding whether targeted therapy would optimise the treatment of GA patients who are HER2 positive. However, this has not been extensively studied in our patients hence the need for this study.
Methods: Recipient tissue microarray blocks were constructed from donor archival formalin fixed paraffin embedded gastric tumour tissue from 80 patients seen over a period of 17 years in a retrospective descriptive study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!